Concerning Trends in HF Epidemiology and Mortality: An HFSA Stats Call to Action!

This session will provide an overview of the HFSA's HF Stats initiative. First, three proposed talks will describe current trends in HF epidemiology, investigate causes for the observed increases in HF mortality in the United States, and compare and contrast HF epidemiology globally versus in the United States. Next, a panel consisting of the three speakers, along with stakeholders from the FDA, CMS, pharmacy, the NIH, the AHA, the HFSA, and a patient, will discuss the epidemiology of HF in the United States. The panelists will have a focused discussion on the potential causes of the worsening in HF mortality and the need for a combined HF awareness campaign. Furthermore, the panelists will discuss how to better implement known, mortality-reducing HF therapies and how to incentivize novel research investigating new approaches to HF management.

Full details and room location will be available onsite via the ASM Mobile App.